Invenire Partners, LP - Q1 2022 holdings

$79.7 Million is the total value of Invenire Partners, LP's 29 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 28.6% .

 Value Shares↓ Weighting
TTEC SellTTEC Holdings Inc$4,689,364,000
-10.1%
56,827
-1.3%
5.88%
+6.6%
NOA SellNorth American Construction Group Ltd$4,018,218,000
-26.5%
278,270
-22.7%
5.04%
-12.8%
UTI SellUniversal Technical Institute Inc$2,657,106,000
-7.2%
300,238
-18.0%
3.33%
+10.0%
ASPN SellAspen Aerogels Inc$1,984,117,000
-41.0%
57,544
-14.8%
2.49%
-30.1%
ASUR SellAsure Software Inc$1,544,167,000
-28.3%
259,524
-5.6%
1.94%
-15.0%
SMLR ExitSemler Scientific Inc$0-48,625
-100.0%
-4.72%
IJR ExitiShares Core S&P Small-Cap ETF$0-85,236
-100.0%
-10.33%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DHI Group Inc4Q3 20227.9%
Tetra Technologies Inc4Q3 20226.5%
Harrow Health Inc4Q3 20228.4%
TTEC Holdings Inc4Q3 20225.9%
Clarus Corp4Q3 20225.9%
Apyx Medical Corp4Q3 20226.5%
InfuSystem Holdings Inc4Q3 20225.1%
PAR Technology Corp4Q3 20224.9%
Cantaloupe Inc4Q3 20225.2%
Marcus Corp4Q3 20224.4%

View Invenire Partners, LP's complete holdings history.

Latest filings
TypeFiled
SC 13G/A2023-03-31
SC 13G2023-01-23
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-13
13F-HR2022-02-14
D/A2019-03-12
D2018-01-02

View Invenire Partners, LP's complete filings history.

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (79717000.0 != 79716738000.0)

Export Invenire Partners, LP's holdings